FDA COVID-19 responses and recommendations this week As the COVID-19 vaccines continue the early stages of circulation in the US, the agency keeps an eye on industry actions and offers advice to key players.
The first wave of US citizens are receiving COVID-19 vaccines in the country’s hospitals, clinics and, in one case, in their cars on a snowy highway. In the meantime, the US Food and Drug Administration (FDA) is maintaining its status as a source of advice for researchers, healthcare professionals, citizens and other affected entities.
The agency has updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures, and highlights on the FDA s response efforts.